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Purpose: This preclinical study investigated the use of QSM MRI to noninvasively 
measure venous oxygen saturation (SvO2) in the hepatic and portal veins.
Methods: QSM data were acquired from a cohort of healthy mice (n = 10) on a 9.4 
Tesla MRI scanner under normoxic and hyperoxic conditions. Susceptibility was 
measured in the portal and hepatic veins and used to calculate SvO2 in each vessel 
under each condition. Blood was extracted from the inferior vena cava of 3 of the 
mice under each condition, and SvO2 was measured with a blood gas analyzer for 
comparison. QSM data were also acquired from a cohort of mice bearing liver tu-
mors under normoxic conditions. Susceptibility was measured, and SvO2 calculated 
in the portal and hepatic veins and compared to the healthy mice. Statistical signifi-
cance was assessed using a Wilcoxon matched‐pairs signed rank test (normoxic vs. 
hyperoxic) or a Mann‐Whitney test (healthy vs. tumor bearing).
Results: SvO2 calculated from QSM measurements in healthy mice under hyperoxia 
showed significant increases of 15% in the portal vein (P < 0.05) and 21% in the 
hepatic vein (P < 0.01) versus normoxia. These values agreed with inferior vena 
cava measurements from the blood gas analyzer (26% increase). SvO2 in the hepatic 
vein was significantly lower in the colorectal liver metastases cohort (30% ± 11%) 
than the healthy mice (53% ± 17%) (P < 0.05); differences in the portal vein were not 
significant.
Conclusion: QSM is a feasible tool for noninvasively measuring SvO2 in the liver 
and can detect differences due to increased oxygen consumption in livers bearing 
colorectal metastases.
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1 |  INTRODUCTION
The measurement of blood susceptibility and venous oxygen 
saturation (SvO2) using QSM MRI has been the focus of sev-
eral studies in recent years.1-4 It has been shown in both animal 
models3 and humans2,5,6 that QSM can quantify changes in 
blood deoxyhaemoglobin content brought about by a hyper-
oxic gas challenge.2,3 This measurement can be used together 
with arterial spin labeling measures of cerebral blood flow 
to estimate the cerebral metabolic rate of oxygen consump-
tion4 and can even quantify regional venous oxygenation in 
the brain.1 To date however, QSM‐based SvO2 research has 
been carried out exclusively in the cerebral vasculature. In 
this study, we aimed to explore whether this technique can be 
extended to noninvasively quantify SvO2 in the liver.
In the liver, the portal vein transports blood from the gut 
and mesentery into the hepatic portal system of the liver. 
From there, blood passes through the liver parenchyma into 
the hepatic veins, which empty into the inferior vena cava 
(IVC). We can define SvO2 measured in the portal vein as 
SpvO2 and that measured in the hepatic vein as ShvO2.
ShvO2 is an indicator of the oxygen supply to demand 
ratio in the liver7; currently it can only be measured inva-
sively via catheterization. Several studies have shown the 
benefit of ShvO2 measurements,8-10 particularly in animals 
and patients that have undergone surgical procedures.11 For 
example, it was found that after Fontan operations (a pallia-
tive procedure performed on children), monitoring ShvO2 in 
the immediate postoperative period could predict the occur-
rence and severity of subsequent acute liver dysfunction.12 
Likewise, it was shown that ShvO2 could be used to gauge the 
regeneration status of the remnant portion of the liver in rats 
that had undergone partial hepatectomy.11,13
Given the demonstrated benefits of invasive ShvO2 mea-
surements, we sought to investigate the potential of QSM to 
measure ShvO2 noninvasively in mice. A hyperoxic gas chal-
lenge was administered to a cohort of healthy mice, and ShvO2 
and SpvO2 were calculated from susceptibility measured 
in branches of the hepatic and portal veins under normoxic 
and hyperoxic conditions. ShvO2 estimates were compared 
to independent measurements of IVC blood samples under 
the same conditions made using a blood gas analyzer. Lastly, 
ShvO2 and SpvO2 were calculated under normoxic condi-
tions in mice that had been inoculated with colorectal liver 
metastases, and values were compared to the healthy cohort. 
It was hypothesized that changes in blood oxygen saturation 
in response to the gas challenge in the healthy animals will be 
systemic and thus will manifest in both portal and hepatic ve-
nous blood. Conversely, given the increased metabolic burden 
that cancer places on host tissue, differences in venous blood 
oxygen saturation between healthy and tumor‐bearing mice 
will manifest in the hepatic vein only, because the disease is 
confined to the liver and thus is not systemic.
2 |  METHODS
2.1 | Animal preparation
All animal studies were performed in accordance with the 
UK Home Office Animals Science Procedures Act (1986) 
and UK National Cancer Research Institute guidelines. CD1 
mice (n = 10, female 8–12 weeks) were anaesthetized using 
4% isoflurane in 100% O2. Respiratory rate was constantly 
monitored using a pressure pad (SA Instruments, Stony 
Brook, NY) and maintained at ~40 to 80 breaths per min by 
varying isoflurane concentration between 1.5% and 3%. Body 
temperature was maintained at 37.5 ± 0.5oC using a warm‐
water circulation system. Mice were selected and scanned in 
random order from each cohort.
Colorectal liver metastases were induced in severe com-
bined immunodeficiency (CD1 background) mice (n = 10), 
which were inoculated with 1 × 106 SW1222 colorectal liver 
metastases cells via intrasplenic injection,14 followed im-
mediately by a splenectomy. Mice were scanned at 19 days 
postsurgery. All animals survived to the end of the study and 
gave analyzable data that is included in the results.
Gases were administered through a nose cone at a rate of 
0.5 L/min. In all cases, MR images were acquired under nor-
moxic conditions while the subject was administered med-
ical air (21% O2/79% nitrogen). Hyperoxia was induced in 
the healthy cohort via the administration of 100% O2. Ten 
minutes were allowed between gases to allow the animals to 
acclimatize before QSM imaging.
2.2 | MRI data acquisition
All subjects were imaged on a 9.4 Tesla (T) MRI system 
(Agilent Technologies, Santa Clara, CA) with a 39‐mm‐
diameter transmit/receive birdcage coil (Rapid Biomed, 
Rimpar, Germany). Susceptibility data were acquired using 
velocity‐compensated15 2D single echo, T2*‐weighted gradi-
ent echo acquisitions. Scan parameters included TR = 1000 
ms; TE = 4 ms; flip angle = 70o; voxel size = 200 × 200 
µm2; readout acquisition bandwidth = 50 kHz; number of av-
erages = 8; and slice thickness = 200 µm2 with no slice gap.
A TE of 4 ms was chosen because it matches the T2* of 
the liver tissue at 9.4T.16 The FOV in each case was adjusted 
to ensure full coverage of the liver and water reference (see 
below), and matrix size was adjusted such that voxel size was 
maintained and the data were spatially isotropic. The number 
of slices varied from 60 to 80 to accommodate full cover-
age of the liver. Mice bearing tumors were at an advanced 
stage of disease and did not tolerate Anesthesia well. Hence, 
to decrease scan time and ensure that all mice survived the 
imaging protocol, all acquisitions were single echo, and sig-
nal averages were reduced to 4 when acquiring data from the 
tumor‐bearing mouse.
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All acquisitions were first‐order flow (i.e., velocity) com-
pensated in all cardinal directions, which required modifica-
tion of the acquisition sequence. Briefly, moving isochromats 
accumulate extra phase with respect to static spins as they 
move through spatial localization gradients. The acquisition 
sequence was modified to include extra lobes in each gradient 
waveform to ensure that static isochromats and those moving 
at a constant velocity would all rephase at the desired echo 
time. The amplitude and duration of the extra lobes were cal-
culated based on those calculated by the standard acquisition 
sequence using the approach taken by Bernstein et al.17
All MRI acquisitions were respiratory‐gated. This was 
done by monitoring the animals’ breathing rate in the scanner 
with a pressure sensitive respiratory monitor (SA Instruments, 
Stony Brook, NY). To avoid respiratory‐related motion arte-
facts, imaging data were only acquired during a flat region 
of the respiratory cycle (i.e., between breaths). Total scan 
time was 20 to 40 mins, depending on respiration rate. As 
the sequences were respiratory‐gated, the average TR was 
dependent on the respiratory rate of each subject; however, 
given the average respiratory rate of ~60 breaths per min, it is 
estimated that the average TR closely reflects the prescribed 
TR of 1000 ms. It was found that this usually allowed the ac-
quisition of data from every slice within a single breath, thus 
further reducing respiratory artefact.
2.3 | Water reference calibration
For quantification of susceptibility from QSM data, a refer-
ence material must be used for calibration.18 In the brain, this 
is usually CSF within ventricles,19 but in the liver no compa-
rable material is available. We therefore included a sample 
of distilled water in the scanner with each subject (Figure 1). 
Briefly, a thin, cylindrical, nitrile membrane (~6 cm length, 
~2 cm diameter) was filled with distilled water and sealed, 
with care taken to ensure that no air became trapped in the 
process. This was placed beneath each mouse in the animal 
holder before scanning commenced. All susceptibility val-
ues are quoted with respect to the water reference.
2.4 | Image processing and analysis
Susceptibility maps were calculated from raw phase data. 
A binary mask was manually segmented around the entire 
F I G U R E  1  T2*‐weighted magnitude images showing example ROIs. (A) Image showing large branch of HV (coronal orientation) including 
liver and stomach. (B) Image showing water reference in situ, including IVC (axial orientation), stomach, and liver tissue. (C) 3D rendering of 
magnitude image displaying PV and HV ROIs and water reference in situ. (D) Image showing large branches of PV (coronal orientation) including 
liver and stomach. Abbreviations: HV, hepatic vein; IVC, inferior vena cava; PV, portal vein; ROI, region of interest
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liver in each magnitude image using ITK‐SNAP20 and in-
cluded a large portion of the water reference. Phase unwrap-
ping and background field suppression were performed 
using a Laplacian‐based Sophisticated Harmonic Artefact 
Reduction for Phase algorithm (Truncated Singular Value 
Decomposition threshold = 0.04, mask erode = 2–3 voxels).21
Susceptibility inversion was carried out using the 
thresholded k‐space division algorithm.22 The threshold of 
the kernel was set to ±0.2 such that absolute values out-
side of this range were set to the threshold value, with the 
appropriate sign depending on the position of the voxel 
within the kernel. This value was found empirically to offer 
the best balance between image fidelity and noise artefact. 
A correction factor of 1.26 (i.e., 1/0.786) was included in 
the deconvolution operation in the algorithm to correct 
for the underestimation inherent to this technique.21 All 
postprocessing was performed in MatLab version 2015b 
(MathWorks, Natick, MA).
Experimenters were not blinded to the treatment group at 
either acquisition or analysis. Regions of interest (ROIs) were 
manually segmented on each magnitude image using ITK‐
SNAP20 and corresponded to large branches of the hepatic 
vein and the portal vein. To avoid partial volume effects, only 
voxels in the highest 20th percentile of susceptibility values 
per ROI were accepted.1
2.5 | Calculating SvO2
The susceptibility difference between blood and water can be 
related to SvO2 by the following:
where Δχdo = 2.26 parts per million (ppm) is the difference 
in susceptibility between fully oxygenated and deoxygenated 
blood at 100% hematocrit (Hct),23 and Hct is the fraction of 
blood composed of erythrocytes, assumed here to be 0.4.3 All 
calculations performed in this study used the water sample as 
the reference point.
2.6 | Blood gas measurement
As an independent measurement for comparison with QSM 
estimates, blood gases were measured invasively in 3 mice 
randomly selected from the healthy cohort. The collection of 
murine hepatic blood is technically very challenging due to 
the size of the vessels under examination and the small vol-
ume of blood that can be sampled in a mouse. On this basis, 
extraction of blood from the portal vein was not possible; com-
parisons were instead drawn from measurements in the IVC, 
which was assumed to be representative of measurements in 
branches of the hepatic vein as they drain into the IVC.
Mice were anesthetized as described above, and a 1 mL 
syringe with 27 G needle was used to extract blood from a 
portion of the IVC within the liver under ultrasound guid-
ance (Vevo 770, VisualSonics, Netherlands). The procedure 
was carried out under normoxic and hyperoxic conditions for 
each mouse as per MRI experiments. Ten minutes were al-
lowed following a change in administered gas to allow the 
animal to acclimatize before sampling. Samples were trans-
ferred from the syringe to a 2 µL heparinized glass tube, and 
then to the blood gas analyzer (RAPIDLab 348EX blood gas 
system; Siemens, Frimley, UK).
2.7 | Statistical analysis
A Wilcoxon matched‐pairs signed rank test was used to as-
sess the statistical significance of the differences between 
normoxic and hyperoxic conditions, and a Mann‐Whitney 
test was used to compare differences between the healthy and 
tumor‐bearing mice. A difference was considered statisti-
cally significant for when P < 0.05.
(1)Δ휒blood - water=Δ휒do ⋅Hct ⋅ (1 - SvO2),
F I G U R E  2  Maximum intensity projections of processed QSM data from a 2.2 mm segment of a representative mouse liver under normoxic 
(left) and hyperoxic (right) conditions. Large branches of the HV are clearly visible in each image (red arrows). Vessels are brighter with respect 
to the liver tissue (by approximately 500 ppb) in the normoxic image compared with the hyperoxic image, indicating a more paramagnetic 
susceptibility
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3 |  RESULTS
3.1 | QSM measurements of blood 
saturation in healthy hepatic vasculature
The susceptibility of the blood in the large branches of mouse 
liver vasculature became more diamagnetic in response 
to the administration of O2. This is illustrated in Figure 2, 
which shows maximum intensity projections from suscepti-
bility data acquired in a healthy mouse liver (11 slices, 2.2 
mm segment), calculated from data acquired under normoxic 
and hyperoxic conditions. The blood vessels in the normoxic 
image are more prominent with respect to the liver tissue due 
to the increased presence of deoxyhemoglobin.
Magnetic susceptibility decreased significantly in the por-
tal and hepatic veins of the healthy animals in response to 
hyperoxia. Mean susceptibility of the blood in the portal vein 
decreased from 380 ± 130 ppb under normoxia to 250 ± 160 
ppb under hyperoxia (P < 0.05 n = 10). Similarly, suscep-
tibility decreased from 430 ± 160 ppb to 230 ± 80 ppb in 
the hepatic vein under normoxic and hyperoxic conditions, 
respectively (P < 0.01, n = 10).
Consequently, venous oxygen saturation increased sig-
nificantly in both the portal and hepatic veins of the healthy 
animals in response to the administration of pure O2 (Figure 
3). Portal venous oxygen saturation (SpvO2) (Figure 3A) in-
creased by 15% from 58% ± 15% during air‐breathing to 73% 
± 18% during hyperoxia (P < 0.05, n = 10), whereas in the 
hepatic vein (Figure 3B) ShvO2 increased by 21% from 53% 
± 18% to 74% ± 9% (P < 0.01).
3.2 | Invasive measurements of hepatic vein 
blood oxygen saturation
There was good agreement between the measurements of 
ShvO2 acquired on the blood gas analyzer and those cal-
culated from QSM measurements (Figure 4). The invasive 
measurement showed a mean increase of 26% in blood 
oxygenation, from 53% ± 10% to 79% ± 11%. This increase 
was not statistically significant. The invasive and noninva-
sive results were compared under normoxic and hyperoxic 
conditions using a Mann‐Whitney test. No significant dif-
ferences were found between the invasive and noninvasive 
results under each condition.
3.3 | QSM measurements of blood 
saturation in CRLM hepatic vasculature
The graphs in Figure 5 show the venous blood oxygen satu-
ration measured under normoxic conditions in the portal 
(A) and hepatic (B) veins of the mice with tumors and the 
healthy cohort. Mean oxygen saturation in the portal vein 
was 44% ± 23% and 58% ± 15% for the disease and healthy 
animals, respectively, and was not significantly different 
between the cohorts. Hepatic venous oxygen saturation 
(ShvO2) in the tumor‐bearing mice was significantly lower 
than that of the healthy cohort (P < 0.05). Mean values 
were 30% ± 11% and 52% ± 18% for the disease and 
healthy animals, respectively.
4 |  DISCUSSION
QSM is an exciting field that has given researchers a novel way 
to explore tissue composition and microstructure. Initial applica-
tions focused on quantifying the changes in tissue iron content 
that are indicative of neurological disorders, but the field has 
grown rapidly to give rise to a diverse range of clinically relevant 
applications. The work described here is the first attempt at using 
QSM to measure the susceptibility, and subsequently calculate 
the oxygen saturation, of blood in the major hepatic vessels.
There are a number of existing MR techniques that allow 
the noninvasive quantification of blood oxygenation, for ex-
ample, R2*,24 T2,25 or SWI26; however, QSM offers a number 
of advantages over other MR methods. For instance, QSM 
F I G U R E  3  Change in venous oxygen saturation in (A) the PV (SpvO2) and (B) the HV (ShvO2). A statistically significant increase in oxygen 
saturation was measured in response to hyperoxia in both vessels (*P < 0.05, **P < 0.01). 
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measures bulk susceptibility, which is directly dependent on 
the iron content of the tissue, whereas R2* is affected by mi-
croscopic field inhomogeneities caused by the presence of iron 
and also includes pure R2 effects. As such, it has been shown 
previously that there is a stronger correlation between tissue 
iron content and susceptibility than with R2*.22 Secondly, 
R2* maps may be affected by intravoxel spin dephasing in 
the vicinity of air–tissue interfaces,27 an issue that is particu-
larly prevalent when performing abdominal imaging. Thirdly, 
QSM has overcome the nonlocal phase contrast as well as the 
tissue geometry and orientation dependence that is known to 
affect SWI.28 As such, it is possible to differentiate between 
positive and negative susceptibility on QSM images, whereas 
the appearance of blood vessels in SW images can depend on 
the orientation of the vessel to the B0 field.
The aim of this study was to assess the ability of QSM to 
measure changes in venous blood oxygenation in the major 
hepatic vessels of mice in response to a hyperoxic gas chal-
lenge. In a previous study, QSM measurements of SvO2 were 
performed in the cerebral vasculature of mice and reported 
changes from ~88% to ~99% in response to hyperoxia.3 
Absolute ShvO2 values calculated in the current study were 
lower (~52%, normoxia; ~74%, hyperoxia). Although there 
is little in the literature concerning ShvO2 in preclinical ex-
periments, the values measured here are broadly in line with 
similar experiments in rats (~60% during normoxia).11,13 
Similarly, previous reports in the literature of the response 
of portal venous blood in rats to hyperoxia describe an in-
crease from ~53% under normoxia to ~93% under hyperoxia 
in healthy control animals.29 It is therefore encouraging that 
this normoxic SpvO2 value is comparable to the measure-
ment made here. Indeed, while the increase under induced 
hyperoxia was greater than we observed, this could be due to 
differences between experimental protocols, the efficiency of 
oxygen delivery, or differences between species. Moreover, a 
good agreement was found between QSM‐based and invasive 
measurements of hepatic venous oxygen saturation during 
both normoxia and hyperoxia. The difference brought about 
by the gas challenge as measured invasively was not statisti-
cally significant, which could be due to the small size of the 
cohort.
In accordance with our hypothesis, there was no sig-
nificant difference between the healthy and tumor‐bearing 
cohorts measured in the portal vein; however, the oxygen 
saturation of blood in the hepatic vein was significantly 
lower in the mice with tumors compared to the healthy co-
hort. The effect was not observed in the portal vein, which 
would indicate that the effect is not systemic, but is instead 
caused as the blood passes through the liver. It is a well‐
known facet of cancer that malignant cells tend to assimilate 
glucose at a higher rate than their normal counterparts.30 
F I G U R E  5  Measurements of venous blood oxygen saturation in mice with colorectal liver metastases and healthy mice. SvO2 values 
were calculated from susceptibility measurements in the PV (A) and the HV (B). Measurements in the HV of the mice with tumors contained 
significantly less oxygen than the healthy cohort
F I G U R E  4  The change in venous oxygen saturation in 
the HV from noninvasive measurements with QSM and invasive 
measurements from the IVC with a blood gas analyzer. There is good 
agreement between the 2 datasets
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The extent to which this increased metabolic burden is ox-
idative, however, remains unclear. It is known that cancer 
cells exhibit a high rate of glycolysis even in aerobic con-
ditions (the Warburg effect),31 but conventional acceptance 
of this being the only metabolic pathway is now being chal-
lenged. Although it has been noted that tumor cell prolifer-
ation increases oxygen consumption by tumor tissues,32,33 
accumulating evidence suggests that the Warburg effect 
is only one aspect of cancer metabolism, which otherwise 
includes aerobic glycolysis, increased pentose phosphate 
pathway, increased macromolecule biosynthesis through 
redox homeostasis, and autophagy.34
This relationship between tumor oxygen use and supply 
places systemic oxygen delivery (e.g., through hyperbaric 
therapy35) as a parameter of potential interest for assessment 
in the clinic. This has been explored previously using inva-
sive means,36 and the sparsity of noninvasive, quantitative 
means of measurement37 provides a clear rationale for our 
study. Moreover, it is known that tumors in the liver have 
an impact on blood flow, but their effect on oxygenation is 
less understood due to a lack of noninvasive measurement 
techniques.38
When performing susceptibility mapping in the brain, it is 
usual to acquire data using a 3D gradient echo sequence, the 
advantages over 2D sequences being cited as superior SNR, 
and that 2D acquisitions may introduce phase inconsistencies 
among adjacent slices.28 It is also noted, however, that 2D 
data are compatible with QSM; and it has been suggested 
in an SWI study of the liver that a 3D sequence may not be 
suitable for abdominal imaging due to the long acquisition 
times.39
There are a number of recent examples in which the QSM 
application being explored has necessitated calculating sus-
ceptibility maps from 2D gradient echo data. These are in-
stances that require fast acquisitions, such as in the case of 
functional QSM40 or for use in patients who are unable to 
remain still for the duration of the scan.41 The latter is par-
ticularly prevalent as the most well‐developed application 
of QSM is to assess changes in focal iron deposition in the 
brains of Parkinson or Huntington disease sufferers. The data 
in this study were all acquired with a 2D gradient echo se-
quence because minimizing acquisition time reduced subject 
mortality, particularly in the tumor‐bearing mice.
The difference in ShvO2 between the mice with tumors 
and healthy mice could have clinical potential. Data in both 
cases were acquired under normoxic conditions. As such, ac-
quisition, necessitated little more than a single standard T2*‐
weighted scan. Tumor burden was not measured in this study 
as the disease model gave rise to a large number of small tu-
mors that spread diffusely throughout the liver volume. This 
meant that they were extremely difficult to identify when 
small, and as they grew had a tendency to clump together, 
making it impossible to differentiate between tumours when 
the livers had been excised. Future experimental work could 
be to perform a longitudinal study to characterize the correla-
tion between tumor burden and ShvO2. Once established, this 
would open the possibility of using QSM to noninvasively 
diagnose or monitor liver cancer, differentiate between be-
nign and malignant lesions, or even to gauge the efficacy of 
treatment regimes.
One limitation of this study was the inability to measure 
the susceptibility of the hepatic artery. At the resolution of 
the imaging protocol used here, the diameter of the hepatic 
artery is of the order of a single voxel, so, measurements were 
undermined by partial volume effects that are known to re-
sult in inaccurate estimations of susceptibility.1 The ability 
to measure the susceptibility, and subsequently calculate the 
oxygen saturation of all three major hepatic vessels, would 
allow a more complete characterization of hepatic hemody-
namics, as well as giving greater insight into hepatic oxy-
gen metabolism, increasing the clinical usefulness of the 
technique. Hepatic arterial susceptibility measurements may 
be made possible by acquiring higher resolution images or 
by using larger animals (e.g., rats); however difficulty may 
be encountered due to pulsatile flow in the arterial vessel. 
By the same token, the measurement of susceptibility in the 
IVC on the QSM images was precluded by the proximity of 
the IVC to the hepatic artery. The acquisition sequence was 
not cardiac‐gated, so did not mitigate artefacts caused by the 
pulsatile nature of the blood flow in the hepatic artery. This 
resulted in an artefact along the phase encode direction of the 
image, acquired such that the artefact passes through the IVC.
The extraction of blood from the portal or hepatic veins 
of a mouse proved to be technically challenging due to its 
size, so the blood for invasive measurements was extracted 
from the IVC. While this is accepted by the authors as a lim-
itation, it is noted that the liver contains 10% to 15% of the 
total blood volume,42 receives 25% of the cardiac output,43 
and consumes ~20% of total resting oxygen.44 Furthermore, 
the hepatic veins are major contributors to the IVC, alongside 
smaller contributions from the renal and iliac veins. As such, 
it was assumed that the oxygenation of the blood in the IVC 
is a reasonable proxy for that in the hepatic veins.
From a clinical translation point of view, this experiment 
should be relatively easy to implement in humans. It has been 
shown in a recent study that QSM data from the entire liver 
can be acquired in ~19 sec, i.e. within one breath hold.45 Data 
could simply be acquired under normoxic conditions, but 
equally both patients and healthy volunteers tolerate hyper-
oxia well. Previous experiments examining the use of QSM 
in the liver46,47 have focused on quantifying iron in the liver 
parenchyma, requiring complicated modifications of acqui-
sition and processing protocols to account for fat. One major 
advantage of measuring the susceptibility of blood in the 
large vessels is that no fat is present; so data can be acquired 
and processed via standard means, although time‐consuming 
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manual masking and ROI‐drawing were necessary. Equally, 
parenchymal iron will have no bearing on the measurements 
discussed in this experiment. The calculation of magnetic 
susceptibility from the phase image—a process also referred 
to in the literature as inversion—rectifies the nonlocal effects 
of susceptibility differences observed in phase images.48 The 
measurements made on QSM images reflect the properties 
of the underlying tissues, independent of orientation or the 
properties of neighboring tissues.22 In this instance, suscep-
tibility measurements were taken from the blood vessels and 
water reference, i.e. areas that do not contain liver iron.
The use of an internal reference for measurements from 
QSM images can be problematic. In the (human) brain, vari-
ability has been shown in a number of regions commonly 
used as references in QSM studies. CSF has been shown to 
have the smallest variability (mean susceptibility 10 ± 14 
ppb), whereas in the same study the mean susceptibility of the 
white matter ranged from 6 ± 20 ppb to 28 ± 23 ppb depend-
ing on the location in which it was measured.19 Furthermore, 
it has been shown that the susceptibility of CSF can change 
under the administration of gases.2 As such, standardization 
of the susceptibility reference is an important factor when 
trying to maximize the benefit of the quantitative nature of 
QSM. Performing QSM in the liver presents additional chal-
lenges for identifying a reference ROI. In comparison to the 
brain, the liver is an amorphous structure and is relatively 
homogeneous. As such, it is difficult to select an internal ref-
erence that is conspicuous enough not only to be identified 
repeatedly in the same animal but is clear and unambiguous 
in an entire study cohort. This difficulty is compounded by 
the fact that the anatomical position of the liver results in sig-
nificant movement over the course of the respiratory cycle.
QSM facilitates the measurement of susceptibility varia-
tions based on the distortion of the B0 field within the FOV 
of the image. As such, it is not necessary that the reference 
be internal to the subject, just that it is independent of ex-
perimental variables, easy to depict and delineate, and easily 
identifiable across a wide range of subjects.19 The external 
reference used here meets each of these criteria; its inclusion 
in the experimental setup is straightforward, although one 
limitation is that the image FOV must be increased to accom-
modate it, potentially resulting in longer acquisition times if 
resolution is to be maintained.
The preliminary nature of this study means that there is 
some room for methodological improvement. For example, the 
control group selected for the tumor‐bearing cohort of CD1 se-
vere combined immunodeficiency mice was nontumor‐bearing 
CD1 nonsevere combined immunodeficiency mice. Although 
a limitation of the study, it was decided that this would reduce 
the number and severity of the interventions performed on the 
animals. Our assumption in this case was that the blood flow 
to the liver would be unaffected between the groups. This is an 
issue that could be addressed in future studies.
Investigators were not blinded to the disease and healthy 
cohorts for this experiment. Data acquisition, processing, and 
analysis were all carried out by the same person. Obvious 
differences between the cohorts precluded the possibility of 
blinding. Although this could be included in the methodology 
in future studies, it would necessitate that all image processing 
(including masking and ROI segmentation) be performed by 
one party while another performed the experimental analysis. 
However, animals were selected and scanned at random from 
either cohort as an attempt to minimize unconscious bias.
The ability to noninvasively perform venous oximetry in 
the liver could have important clinical implications. Hepatic 
venous oxygen saturation is a useful metric and has been 
used to assess hepatic oxygen kinetics in studies focusing on 
topics as diverse as hemodialysis,49 acute and chronic heart 
failure,50 and hepatic ischemic/reperfusion injuries.51,52 
Furthermore, improvements in diagnostic radiology, patient 
selection, and operative technique mean that partial hepa-
tectomy has increasingly become a more viable treatment 
option in cases of hepatic lesions, both malignant and be-
nign. It is known that the regenerating liver places an in-
creased metabolic burden on patients who have undergone 
the procedure and previously has been shown that ShvO2 
reflects the metabolic status of the remnant liver.11,13 The 
ability to relate magnetic susceptibility to SvO2 through 
QSM offers a way to assess this in a noninvasive fashion.
In this study, we employed QSM to assess changes in 
SvO2 in the portal and hepatic veins, which we modulated 
with a hyperoxic gas challenge. This is the first report that 
examines the ability of QSM to assess oxygen changes in the 
major hepatic vessels. We have shown that it is possible to 
detect statistically significant differences in blood oxygen-
ation in response to hyperoxia. Moreover, our measurements 
showed good accordance with invasive measurements from 
the IVC made with a blood gas analyzer, and that it is possi-
ble to detect significant differences between the hepatic ve-
nous oxygen saturations of a group of healthy animals and a 
group with liver cancer.
5 |  CONCLUSION
QSM is a feasible tool for noninvasively measuring blood 
oxygenation in the major hepatic vessels. Measurements 
derived from QSM images can detect differences in ShvO2 
between well‐oxygenated and partially deoxygenated blood, 
and furthermore can detect differences between the ShvO2 of 
healthy mice and mice with tumors.
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